Glenmark Pharmaceuticals informs about media release

25 Jan 2024 Evaluate
Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Jiangsu Alphamab Biopharmaceuticals, 3D Medicines (Beijing) and Glenmark announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1000.95 -19.80 (-1.94%)
09-May-2024 14:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.20
Dr. Reddys Lab 5914.55
Cipla 1358.95
Zydus Lifesciences 976.70
Lupin 1592.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.